Inês Baldeiras

CSF biomarker variability in the Alzheimer's Association quality control program

Niklas Mattsson, Ulf Andréasson, Staffan Persson et al. · Alzheimer s & Dementia · 2013 · 385 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

Willemijn J. Jansen, Olin Janssen, Betty M. Tijms et al. · JAMA Neurology · 2022 · 288 citations · Full text

Medicine, Neurology, Neuroscience +17

Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease

Sandra I. Mota, Rui O. Costa, Ildete L. Ferreira et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2015 · 179 citations

Life Sciences, Neurobiology, Neuroscience +16

Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease

Maria João Leitão, Anuschka Silva‐Spínola, Isabel Santana et al. · Alzheimer s Research & Therapy · 2019 · 168 citations · Full text

Medicine, Neurology, Neuroscience +17

Peripheral Oxidative Damage in Mild Cognitive Impairment and Mild Alzheimer's Disease

Inês Baldeiras, Isabel Santana, Maria Helena Garrucho et al. · Journal of Alzheimer s Disease · 2008 · 155 citations

Life Sciences, Neurology, Neuroscience +17